A novel lipopeptide hydrogel delivery system could improve peptide-based cancer vaccines, providing a dual approach by acting as both a delivery platform and an immune response booster.
While tested in liver cancer, the approach may be adapted for prostate cancer, enhancing the immune system’s ability to fight the disease.
A new study reveals how a clotting protein and blood platelets can promote cancer progression and suppress immune responses to cancer
Adaptive Therapy as it applies to the treatment of cancer: Part One - A Personal Perspective Phase 2 trial: adaptive ADT for metastatic castration sensitive prostate cancerMetastasis Directed Therapy (MDT) is here to stay for Oligometastatic Patients !!! Part(1) SABR/SBRTPreclinical, interesting and easy to implement: kaempferol shows promise in treating emotional stress-aggravated prostate cancer metastasis
